Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of JTT-305 in postmenopausal women with osteoporosis
2007-005474-31Phase 2Terminated
- Sponsor
- Akros Pharma Inc.
- Start
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of encaleret in osteoporosis, sponsored by Akros Pharma Inc.. Started Dec 2007; status: terminated.
02
Drugs
encaleret
03
Conditions
osteoporosis
Beyond the preview
Go deeper on 2007-005474-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005474-31.